Central Texas Retina and Vitreous

What Central Texas Retina and Vitreous does

Central Texas Retina and Vitreous is a single-location, retina-only ophthalmology practice headquartered at 7200 North Mopac Expressway, Suite 200, Austin, Texas, founded by Dr. Stephen Smith, MD, who is the sole board-certified retina specialist on staff. The practice is structured as a solo physician subspecialty clinic with 1-10 total staff, supported by an external partnership with Northwest Hills Surgical Facilities and regional health systems for operative and inpatient retina care. Its clinical scope is restricted to posterior-segment disease (retina, macula, vitreous), explicitly differentiated from general ophthalmology, and it functions as a referral center serving community optometrists, general ophthalmologists, and LASIK providers across Central Texas.

The service portfolio spans the full management spectrum for visually threatening posterior-segment conditions. Diagnostic capabilities include dilated retinal examinations plus retinal imaging (OCT, fluorescein angiography, retinal photography). Treatment offerings include in-office intravitreal injection therapy (anti-VEGF such as Avastin and Lucentis), laser photocoagulation for tears, diabetic retinopathy, and vascular occlusions, and surgical interventions including vitrectomy, macular hole repair, epiretinal membrane surgery, and scleral buckle procedures performed at partner surgical facilities. Key disease areas are age-related macular degeneration, diabetic retinopathy and diabetic macular edema, retinal tears and detachment, retinal vein occlusion, macular hole, macular edema, and flashes/floaters evaluation.

The business model is professional-services clinical revenue under standard U.S. medical billing. The practice accepts all major insurance carriers (Aetna, BCBS, Cigna, Humana, Medicare, Medicaid, United Healthcare) and offers patient financing; individual procedure pricing is not publicly disclosed. The go-to-market is sales-led and referral-driven rather than direct-to-consumer, supplemented by a website (Glacial Multimedia-designed) with patient education content and online appointment requests. The practice is privately held by Dr. Smith with no external investors, no funding rounds, no disclosed revenue, and operates exclusively in the Austin/Central Texas geography.

Name

Central Texas Retina and Vitreous

Legal name

Central Texas Retina & Vitreous

Website

https://centraltxretina.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Central Texas Retina and Vitreous is a single-physician, retina-only ophthalmology practice in Austin, Texas, founded and operated by Dr. Stephen Smith, MD, providing medical and surgical care for posterior-segment conditions to adults and seniors across Central Texas.

Ownership category

akta.pro rank

Product category

Retina and Vitreous Ophthalmology Services

NAICS

Offices of Physicians (6211)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Retina & Vitreous Specialists (HLAKAKAE)

akta.pro secondary industry

Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)

Keywords

• Retina care services
• Vitreoretinal surgery
• Macular degeneration treatment
• Diabetic retinopathy care
• Ophthalmology practice

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Clinical Services Revenue: Revenue generated from comprehensive retinal evaluations, ongoing disease management, in-office laser treatments, intravitreal injections, and surgical planning for vitrectomy and other retina procedures.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Central Texas Retina and Vitreous is a single-physician retina subspecialty practice in Austin, Texas that diagnoses and treats diseases of the retina, macula, and vitreous. Services span comprehensive dilated retinal examinations, advanced retinal imaging (OCT, fluorescein angiography), in-office procedures such as intravitreal injections and laser photocoagulation, and surgical interventions including vitrectomy, scleral buckle, and macular hole repair.

Product overview

Central Texas Retina and Vitreous is a single-location, retina-only ophthalmology practice in Austin, Texas, specializing in the diagnosis and treatment of diseases of the retina, macula, and vitreous. The practice operates as a unified clinical service offering rather than a platform product. Services include comprehensive dilated retinal examinations, advanced retinal imaging (OCT, fluorescein angiography), and a full spectrum of treatments ranging from in-office procedures (intravitreal injections, laser photocoagulation) to surgical interventions (vitrectomy, scleral buckle). The practice focuses on medically management of complex posterior-segment conditions including macular degeneration, diabetic retinopathy, retinal vein occlusions, macular holes, epiretinal membranes, and retinal detachment.

Differentiator

Problem solved

Functional benefit

Products and services

• Macular Degeneration Treatment Diagnosis and treatment of age-related macular degeneration (dry and wet forms) including Amsler grid monitoring, vitamin supplementation, and intraocular injection therapies such as Avastin and Lucentis for adult and senior patients in Austin.
• Diabetic Retinopathy Treatment Comprehensive care for diabetic retinopathy including monitoring, laser treatment, intravitreal injections, and surgical intervention for proliferative disease and diabetic macular edema in diabetic patients.
• Retinal Detachment and Tears Treatment Laser photocoagulation for retinal tears and surgical repair (vitrectomy, scleral buckle) for retinal detachment in patients at risk of or experiencing detachment.
• Retinal Vein Occlusion Treatment Diagnosis and treatment of central and branch retinal vein occlusions using ocular imaging (OCT, fluorescein angiogram) and management of resulting macular edema with laser and intravitreal injections.
• Macular Hole Surgery Surgical repair of macular holes using vitrectomy with traction removal and gas bubble placement followed by face-down positioning for recovery.
• Flashes and Floaters Evaluation Urgent dilated examination to rule out retinal tears, retinal detachment, or vitreous hemorrhage in patients experiencing flashes and floaters.
• Vitrectomy Surgery Microsurgical removal of vitreous gel for conditions including retinal detachment, macular hole, macular pucker, epiretinal membrane, and vitreous hemorrhage.
• Macular Edema Treatment Treatment of fluid buildup or swelling in the macula caused by diabetes, hypertension, macular degeneration, or inflammation using injection therapy, laser, or management of underlying conditions.
• Dilated Retinal Examination Comprehensive posterior-segment evaluation for symptoms such as flashes, floaters, visual changes, and for high-risk patients including those with diabetes.
• Retinal Imaging and Diagnostics Advanced diagnostic imaging including retinal photography, optical coherence tomography (OCT), and fluorescein angiography (FA) for evaluation of retinal conditions.
• Intravitreal Injection Therapy In-office injection of medication into the vitreous for treatment of macular degeneration, diabetic retinopathy, macular edema, and vascular occlusions.
• Laser Photocoagulation Laser treatment for retinal tears, diabetic retinopathy, macular edema from diabetes or vein occlusion, and regression of abnormal blood vessels in proliferative disease.

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Northwest Hills Surgical FacilitiescoreStrategic or Co-development PartnerListed retina specialist at Northwest Hills Surgical Facilities for operative retina care. Practice partners with regional hospitals and surgical centers for surgical procedures requiring operating room facilities.
• Regional Health SystemscoreStrategic or Co-development PartnerInclusion as a covered provider in regional hospital financial assistance programs reflects integration into major Central Texas health systems. Coordinates with regional health systems for patient care.

Scale indicators1 record

Recent moves5 records

Expansion highlights2 records

Broad incumbents

• Retina Consultants of America: Private-equity-backed national platform aggregating independent retina specialty practices. Comparable because it is built from independent retina practices like CTRV, representing both an industry aggregator and a long-term strategic acquirer of similar subspecialty clinics.

Direct peers

• Vitreoretinal Associates Medical Group: Los Angeles-area vitreoretinal specialty practice offering the same retina-only clinical service mix (diagnosis through vitrectomy). Comparable as a physician-owned subspecialty clinic anchored to a single metro referral ecosystem.
• Mid-Atlantic Retina: Long-established multi-physician vitreoretinal specialty group serving the Philadelphia region. Comparable as a dedicated retina-only clinical practice with a similar service mix (intravitreal injections, lasers, vitrectomy) and referral-driven GTM.
• Palmetto Retina Center: Southeast U.S. retina subspecialty practice with a comparable referral-based, retina/macula/vitreous-only clinical model. Relevant as a same-business-model peer — single-metro dedicated retina group with surgical facility partnerships.
• Texas Retina Associates: Largest dedicated retina specialty practice in Texas, with multiple offices including Austin and Lubbock (the founder's prior employer). Operates the same subspecialty model (retina/macula/vitreous only) with a multi-physician group structure, making it the most direct comparator in CTRV's home market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Central Texas Retina and Vitreous